BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Aug. 18, 2010
View Archived Issues
New Agent Boosts Prospects for Photodynamic Therapy
Read More
Genetic Testing Guidelines Offer Common Principles
Read More
Mayo Clinic, Cardio3 Report on Heart Failure Therapy
Read More
Other News To Note
Read More
PregLem In-Licenses Merck Serona's Jun Kinase Inhibitor
PregLem SA is in-licensing an oral, preclinical Jun kinase inhibitor, bentamapimod (AS602801), from Merck Serono SA, for prevention of postsurgical abdominal adhesions and endometriosis in patients. (BioWorld International)
Read More
Angels Fly in When Funds Dry up From VCs, Banks
Read More